No Data
No Data
Analysts Offer Insights on Healthcare Companies: InMode (INMD), Fortrea Holdings Inc. (FTRE) and Lexeo Therapeutics, Inc. (LXEO)
Fortrea Holdings Inc. Announces New Principal Accounting Officer
Express News | Fortrea Appoints Robert Parks as Chief Accounting Officer
Evercore Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Maintains Target Price $31
Evercore analyst Elizabeth Anderson CFA maintains $Fortrea Holdings(FTRE.US)$ with a buy rating, and maintains the target price at $31.According to TipRanks data, the analyst has a success rate of 37.
Express News | Fortrea Has Launched Its Artificial Intelligence Innovation Studio To Develop And Deploy Ai And Machine Learning Technologies For Clinical Research Process
Express News | Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery